CHRS (Coherus Biosciences) Backtesting: Unlocking Investment Insights

CHRS (Coherus Biosciences) backtesting is an important tool for STOCKS investors looking to test the effectiveness of their strategies. Backtesting CHRS (Coherus Biosciences) strategies involves analyzing historical market data to evaluate how well a particular approach would have performed in the past. By using backtesting software, investors can simulate trading strategies and gain insights into potential future outcomes. This process helps investors make more informed decisions when it comes to CHRS (Coherus Biosciences) investments and improve their overall portfolio performance. So, let's dive into the world of CHRS (Coherus Biosciences) backtesting and explore the benefits it offers to savvy investors.

Profit with CHRS strategies Start for Free with Vestinda
CHRS
Backtest CHRS & Stocks, Forex, Indices, ETFs, Commodities
  • 100,000 available assets New
  • years of historical data
  • practice without risking money
Image containing Tesla logo, US Dollar bills and Gold bars
Backtest & discover winning strategy Your winning strategy might be just a backtest away. 🤫

Automated Strategies & Backtesting results for CHRS

Here are some CHRS trading strategies along with their past performance. You can validate these strategies (and many more) for free on Vestinda across thousands of assets and many years of historical data.

Automated Trading Strategy: Math vs. the market on CHRS

Based on the backtesting results statistics for the trading strategy conducted from December 21, 2021, to December 21, 2023, several key findings stand out. The profit factor for this period was 0.35, indicating that the strategy experienced a substantial loss. The annualized return on investment (ROI) was -25.41%, reflecting the strategy's underperformance compared to a passive investment approach. On average, the holding time for each trade was approximately 5 days and 23 hours, while only 0.23 trades were executed per week. With 25 closed trades in total, the winning trades percentage reached 56%. Remarkably, the strategy outperformed the buy and hold strategy by generating excess returns of 340.25%.

Backtesting results
Backtesting results
Dec 21, 2021
Dec 21, 2023
CHRSCHRS
ROI
-50.83%
End Capital
$
Profitable Trades
56%
Profit Factor
0.35
No results icon
No trades were made during this period.

Try adjusting the interval OR Reset to initial period

No results icon
No backtesting results found for selected period.

Choose another period and try again.

Invested amount
Drag handle or
Backtesting period
Reset
Drag handles or pick dates
Backtesting snapshot
The snapshot below does not reflect new Backtesting period results.
CHRS (Coherus Biosciences) Backtesting: Unlocking Investment Insights - Backtesting results
I want gains from trading

Automated Trading Strategy: Follow the trend on CHRS

During the period from November 5, 2022, to November 5, 2023, the backtesting results of a trading strategy revealed some significant statistics. The annualized Return On Investment (ROI) for the strategy was recorded at a staggering -54.03%, indicating a substantial loss over the time frame. On average, each trade was held for approximately 2 weeks and 2 days, demonstrating a relatively short-term trading approach. Surprisingly, the frequency of trades remained comparatively low, with an average of only 0.13 trades per week. A total of 7 trades were closed during the period, and unfortunately, none of these trades were successful, resulting in a 0% winning trades percentage. Overall, these statistics highlight a challenging trading period for the strategy, characterizing it as highly unprofitable and unsuccessful during the mentioned time frame.

Backtesting results
Backtesting results
Nov 05, 2022
Nov 05, 2023
CHRSCHRS
ROI
-54.03%
End Capital
$
Profitable Trades
0%
Profit Factor
0
No results icon
No trades were made during this period.

Try adjusting the interval OR Reset to initial period

No results icon
No backtesting results found for selected period.

Choose another period and try again.

Invested amount
Drag handle or
Backtesting period
Reset
Drag handles or pick dates
Backtesting snapshot
The snapshot below does not reflect new Backtesting period results.
CHRS (Coherus Biosciences) Backtesting: Unlocking Investment Insights - Backtesting results
I want gains from trading

Backtesting CHRS: A Comprehensive Step-by-Step Guide

  1. Collect historical data for CHRS, including price and volume information.
  2. Choose a backtesting platform or software to analyze the data.
  3. Define a trading strategy or set of rules to backtest on CHRS.
  4. Input the historical data and trading strategy into the backtesting platform.
  5. Conduct the backtest, following the defined strategy, and record the results.

News Impact on CHRS Backtesting Results

News events can have a significant impact on the backtesting of CHRS. A sudden positive news can lead to a sharp increase in the stock price. This would result in an inflated performance of the backtest, potentially leading to unreliable conclusions. On the other hand, negative news can cause a sharp decline in the stock price, making the backtest results seem worse than they actually are. These fluctuations can introduce bias and distort the accuracy of the backtesting. It is crucial to account for and analyze these news events when evaluating the performance of CHRS, as they can greatly influence the outcomes of the backtesting analysis.

Volatility Impact on CHRS Strategy Performance

Analyzing CHRS strategy performance during volatile periods is crucial for investors.

During such periods, the stock market experiences drastic fluctuations, causing uncertainties.

Investors must carefully examine CHRS's performance to make informed decisions.

Short-term price adjustments are common during volatile times, making it essential to evaluate CHRS's ability to withstand market turbulence.

Assessing CHRS's risk management strategies and its response to unforeseen events is vital.

Investors should analyze the company's financial stability and ability to adapt to changing market conditions effectively.

By closely observing CHRS's performance during volatile periods, investors can anticipate potential risks and opportunities.

Thorough analysis helps investors formulate strategies to mitigate risks and maximize returns in uncertain times.

CHRS Backtesting: Debunking Common Misconceptions

There are several common misconceptions about CHRS backtesting that need to be addressed. Firstly, some people assume that backtesting guarantees future results, but this is not true. Secondly, there is a misconception that backtesting can accurately predict market volatility, which is also false. Additionally, it is often misunderstood that backtesting can eliminate all risks associated with investing in CHRS. However, while it can provide historical data, it cannot account for unforeseen events or changes in market conditions. Moreover, another misconception is that backtesting can replace in-depth analysis and research. In reality, backtesting should be used as a tool to complement other investment strategies and not be solely relied upon for decision making. It is important for investors to have a clear understanding of these common misconceptions to make informed and realistic investment decisions regarding CHRS.

Trusted by Traders Worldwide
Upgrade my trading experience Start for Free

Frequently Asked Questions

How does slippage impact CHRS backtesting results?

Slippage refers to the difference between the expected price of a trade and the actual price at which it is executed. In the context of CHRS backtesting, slippage can significantly impact the accuracy and reliability of the results. If backtesting doesn't account for slippage, it may overestimate the profit potential or underestimate the risk associated with a strategy. By failing to consider real-world execution challenges, such as market liquidity or order size, backtesting results might not reflect actual performance accurately. Slippage, therefore, plays a crucial role in assessing the viability and effectiveness of a trading strategy during backtesting.

Can backtesting be done on CHRS strategies with algorithmic stablecoins?

Yes, backtesting can be done on CHRS (Cryptocurrency Hedge Ratio Strategies) with algorithmic stablecoins. Backtesting involves simulating trading strategies using historical data to evaluate their performance. Algorithmic stablecoins, which dynamically adjust their supply to maintain price stability, enable the creation of more sophisticated CHRS. By employing backtesting techniques, traders can assess the effectiveness of CHRS strategies based on algorithmic stablecoins, gaining insights on potential profitability and risk levels. This process helps refine and optimize trading strategies before their implementation in real-world scenarios.

Can backtesting help evaluate the impact of macroeconomic shocks on CHRS?

Backtesting can indeed be utilized to evaluate the impact of macroeconomic shocks on CHRS (capitalization, housing, and real estate sectors). By simulating historical data, backtesting can provide insights into how macroeconomic shocks affect these sectors' performance. It allows us to analyze different scenarios and assess how various shocks, such as interest rate changes or GDP fluctuations, influence CHRS. Backtesting helps evaluate the robustness of models or investment strategies and enables investors to make informed decisions based on the historical performance of these sectors during macroeconomic shocks.

How do you create a strategy in TradingView?

To create a strategy in TradingView, start by defining your objective and overall trading approach. Next, analyze market trends, historical data, and technical indicators to identify potential entry and exit points. Develop clear rules for buy/sell signals and risk management. Use TradingView's built-in Pine Script language to code your strategy, incorporating conditions, alerts, and desired trading actions. Consider backtesting your strategy on historical data to evaluate its performance. Regularly monitor and adjust your strategy based on market conditions and refine your approach over time. Remember to stay disciplined and adhere to your predefined rules to maximize your chances of success.

How to do manual backtesting?

Manual backtesting involves manually reviewing historical price charts and executing trades based on past data. To perform manual backtesting, start by selecting a specific trading strategy or set of rules. Then, go back to an earlier period and start analyzing the price movement, identifying potential entry and exit points based on the pre-determined strategy. Keep track of each trade's performance and record all relevant data. Although time-consuming, manual backtesting allows traders to gain insights into the effectiveness of their strategy and make adjustments if necessary.

How to backtest a CHRS strategy with multiple indicators?

To backtest a CHRS strategy with multiple indicators, follow these steps:

1. Define the strategy's rules based on the indicators.

2. Gather historical data for the desired timeframe.

3. Apply the strategy's rules to the data and track the trades that would have been executed.

4. Calculate performance metrics like profit/loss, win rate, and risk-reward ratio.

5. Validate the results by comparing them with other time periods or benchmark strategies.

6. Adjust the strategy if necessary, considering different combinations of indicators and parameter values.

7. Repeat the process by backtesting with different timeframes and market conditions.

Conclusion

In conclusion, CHRS backtesting is a valuable tool for investors to evaluate the effectiveness of their strategies. By analyzing historical market data and simulating trading strategies, investors can gain insights into potential future outcomes and make informed decisions when it comes to CHRS investments. However, it is crucial to consider the impact of news events on backtesting results, as they can introduce bias and distort accuracy. Additionally, investors should analyze CHRS's performance during volatile periods to assess risk management strategies and identify potential risks and opportunities. It is important to address common misconceptions about backtesting to ensure realistic and informed investment decisions.

Profit with CHRS strategies Start for Free with Vestinda
Get Your Free CHRS Strategy
Start for Free